|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
|
US4241046A
(en)
|
1978-11-30 |
1980-12-23 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4925661A
(en)
|
1984-04-19 |
1990-05-15 |
Leaf Huang |
Target-specific cytotoxic liposomes
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US4755388A
(en)
|
1984-11-09 |
1988-07-05 |
The Regents Of The University Of California |
Liposome-encapsulated 5-fluoropyrimidines and methods for their use
|
|
DE3542773A1
(de)
|
1985-12-04 |
1987-06-11 |
Roehm Pharma Gmbh |
Hautwirksame pharmaka mit liposomen als wirkstofftraeger
|
|
US4828837A
(en)
|
1987-03-30 |
1989-05-09 |
Liposome Technology, Inc. |
Non-crystalline minoxidil composition, its production and application
|
|
US5077211A
(en)
|
1988-07-06 |
1991-12-31 |
Applied Genetics, Inc. |
Purification and administration of dna repair enzymes
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5043164A
(en)
|
1989-01-17 |
1991-08-27 |
The University Of Tennessee Research Corporation |
Blood-stable, cholesterol-free liposomes
|
|
US5064655A
(en)
|
1989-02-24 |
1991-11-12 |
Liposome Technology, Inc. |
Liposome gel composition and method
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
EP0532767B1
(en)
|
1991-04-05 |
1997-03-05 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
3-Phenoxybenzyl(idene)pyrrolidine derivatives, their preparation and their use as muscarinic cholinergic agents
|
|
US5491069A
(en)
|
1994-02-18 |
1996-02-13 |
The Regents Of The University Of California |
Biomarkers of cell senescence
|
|
US5888764A
(en)
|
1995-01-20 |
1999-03-30 |
Uab Research Foundation |
Human fas gene promoter region
|
|
DE19713393C2
(de)
|
1997-04-01 |
2002-12-05 |
Apotech Res & Dev Ltd |
Flip-Gen und Flip-Protein
|
|
JPH11349568A
(ja)
|
1998-06-08 |
1999-12-21 |
Maruho Co Ltd |
ラクタム誘導体及びその医薬用途
|
|
CA2338328A1
(en)
*
|
1998-07-21 |
2000-02-03 |
Thomas Jefferson University |
Small molecule inhibitors of bcl-2 proteins
|
|
AUPR038200A0
(en)
|
2000-09-26 |
2000-10-19 |
Beta Peptide Foundation Pty Ltd, The |
Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
|
|
ATE474568T1
(de)
|
2001-05-30 |
2010-08-15 |
Univ Michigan |
Synergistische kombination von (-) -gossypol mit docetaxel oder paclitaxel zur behandlung von krebs.
|
|
ATE345504T1
(de)
|
2002-05-07 |
2006-12-15 |
Pasteur Institut |
Screeningverfahren für peptide, die die bindung von pp1c an bcl-2, bcl-xl und bcl-w proteine inhibieren
|
|
WO2004066915A2
(en)
|
2003-01-23 |
2004-08-12 |
The Trustees Of Columbia University In The City Of New York |
Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
US20050208151A1
(en)
|
2003-10-30 |
2005-09-22 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with FLIP antagonists
|
|
US7973161B2
(en)
|
2003-11-13 |
2011-07-05 |
Abbott Laboratories |
Apoptosis promoters
|
|
EP1692486B1
(en)
|
2003-12-12 |
2015-10-28 |
Saint Louis University |
Biosensors for detecting macromolecules and other analytes
|
|
EP2261218B1
(en)
|
2004-05-26 |
2013-04-03 |
Eisai R&D Management Co., Ltd. |
Imidazole compound for use as an intermediate in the production of cinnamide compounds
|
|
BRPI0514504A
(pt)
|
2004-08-20 |
2008-06-10 |
Univ Michigan |
pequenas moléculas inibidoras de membros da famìlia bcl-2 anti-apoptóticos e os usos das mesmas
|
|
US7533068B2
(en)
|
2004-12-23 |
2009-05-12 |
D-Wave Systems, Inc. |
Analog processor comprising quantum devices
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
EP2135078B1
(en)
|
2007-03-09 |
2013-08-21 |
DiscoveRx Corporation |
Methods for identifying agents and their use for the prevention or stabilization of fibrosis
|
|
BRPI0810082A2
(pt)
|
2007-03-29 |
2014-10-21 |
Novartis Ag |
3-imidazolil-indóis para o tratamento de doenças proliferativas
|
|
US20100310504A1
(en)
|
2007-09-26 |
2010-12-09 |
Lowe Scott W |
Methods for treating fibrosis by modulating cellular senescence
|
|
US20120156134A1
(en)
|
2007-12-20 |
2012-06-21 |
Shayne Squires |
Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
|
|
US20090312373A1
(en)
|
2008-03-11 |
2009-12-17 |
The General Hospital Corporation |
Methods for the treatment of cancer using piperlongumine and piperlongumine analogs
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
US20100086941A1
(en)
|
2008-10-01 |
2010-04-08 |
Adami Guy R |
Methods for determining aged based accumulation of senescent cells using senescence specific DNA damage markers
|
|
EP2376085B1
(en)
|
2008-12-19 |
2014-02-26 |
Genentech, Inc. |
Compounds and methods of use
|
|
KR101685718B1
(ko)
|
2008-12-19 |
2016-12-12 |
제넨테크, 인크. |
헤테로시클릭 화합물 및 사용 방법
|
|
BRPI1016102A2
(pt)
|
2009-04-15 |
2015-09-01 |
Sanford Burhnham Medical Res Inst |
Inibidores de proteínas anti-apoptótica baseados em naftaleno
|
|
ES2546294T7
(es)
|
2009-05-26 |
2024-06-06 |
Abbvie Ireland Unlimited Co |
Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias
|
|
EP2289528A1
(en)
|
2009-07-21 |
2011-03-02 |
DSM IP Assets B.V. |
Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
|
|
US20120157455A1
(en)
|
2009-09-02 |
2012-06-21 |
Canthera Therapeutics, Inc. |
Compounds And Compositions For Treating Cancer
|
|
US8318737B2
(en)
|
2009-09-02 |
2012-11-27 |
Canthera Therapeutics Inc. |
Compounds and compositions for treating cancer
|
|
US8349832B2
(en)
|
2009-09-02 |
2013-01-08 |
Canthera Therapeutics |
Compounds and compositions for treating cancer
|
|
EP2519260A2
(en)
|
2009-12-31 |
2012-11-07 |
Deutsches Krebsforschungszentrum |
Novel modulators of trail signalling
|
|
CN101774875A
(zh)
|
2010-01-08 |
2010-07-14 |
北京欧凯纳斯科技有限公司 |
一种荜拔酰胺类化合物的合成方法
|
|
CN102125552A
(zh)
|
2010-01-20 |
2011-07-20 |
李绍路 |
荜茇酰胺衍生物在制备治疗癌症的药物中的用途及其药物组合物
|
|
CN102146054A
(zh)
|
2010-02-10 |
2011-08-10 |
新昌县来益科技开发有限公司 |
荜茇酰胺衍生物及其药物组合物和在制备抑制肿瘤生长的药物中的用途
|
|
WO2011130395A1
(en)
|
2010-04-13 |
2011-10-20 |
University Of Utah Research Foundation |
Inhibitors of flip to treat cancer
|
|
RU2593231C2
(ru)
|
2010-11-23 |
2016-08-10 |
ЭббВи Айэленд Анлимитед Компани |
Способы лечения с использованием селективных ингибиторов bcl-2
|
|
KR101762724B1
(ko)
|
2011-01-25 |
2017-07-28 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
Bcl-2/bcl-xl 억제제 및 이를 이용한 치료 방법
|
|
CN103958508B
(zh)
|
2011-10-14 |
2019-02-12 |
艾伯维公司 |
用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂
|
|
EP2602330A1
(en)
|
2011-12-07 |
2013-06-12 |
Palacky University, Olomouc |
Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance
|
|
KR102438072B1
(ko)
|
2012-01-12 |
2022-08-31 |
예일 유니버시티 |
E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
|
|
WO2013178821A1
(en)
|
2012-06-01 |
2013-12-05 |
Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. (FLI) |
Inhibitors of the notch signalling pathway and secretion for use in medicine
|
|
US9108923B2
(en)
|
2012-07-20 |
2015-08-18 |
Howard Hughes Medical Institute |
Compounds, compositions, and methods for cancer therapy
|
|
CN103601670B
(zh)
|
2012-11-20 |
2016-06-15 |
中国人民解放军第二军医大学 |
荜拔酰胺类似物及其制备方法与应用
|
|
US10279018B2
(en)
|
2012-12-03 |
2019-05-07 |
Unity Biotechnology, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
GB201311910D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel Compounds
|
|
EP2945940B1
(en)
|
2013-01-16 |
2020-07-15 |
The Regents of The University of Michigan |
Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer
|
|
BR112015026702A2
(pt)
|
2013-04-21 |
2018-02-06 |
Yeda Res And Developmente Co Ltd |
métodos de extermínio de células senescentes
|
|
US9993472B2
(en)
|
2014-01-28 |
2018-06-12 |
Unity Biotechnology, Inc. |
Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
|
|
US10002107B2
(en)
|
2014-03-12 |
2018-06-19 |
D-Wave Systems Inc. |
Systems and methods for removing unwanted interactions in quantum devices
|
|
EP4649963A3
(en)
|
2014-04-14 |
2026-05-13 |
Arvinas Operations, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
CN106456699B
(zh)
|
2014-05-05 |
2021-07-02 |
生物风险投资有限责任公司 |
作为抗老化剂抑制抗凋亡的Bcl-2蛋白的组合物和方法
|
|
CA2955972A1
(en)
|
2014-07-22 |
2016-01-28 |
Bioventures, Llc. |
Compositions and methods for selectively depleting senescent cells
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
US10552755B2
(en)
|
2014-08-22 |
2020-02-04 |
D-Wave Systems Inc. |
Systems and methods for improving the performance of a quantum processor to reduce intrinsic/control errors
|
|
US9694084B2
(en)
*
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US20180021323A1
(en)
|
2015-01-22 |
2018-01-25 |
Bioventures, Llc |
Flip - a selective molecular target of senescent cells
|
|
WO2016118855A1
(en)
|
2015-01-22 |
2016-07-28 |
Board Of Trustees Of The University Of Arkansas |
Compositions and methods for selectively depleting senescent cells comprising death receptors
|
|
US20180000816A1
(en)
|
2015-02-06 |
2018-01-04 |
Unity Biotechnology, Inc. |
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
|
|
CN107851218A
(zh)
|
2015-02-10 |
2018-03-27 |
D-波系统公司 |
用于量子处理器架构的系统、装置、物品和方法
|
|
AU2016232705C1
(en)
|
2015-03-18 |
2021-06-17 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
WO2016145536A1
(en)
*
|
2015-03-18 |
2016-09-22 |
Immunobiochem Corporation |
Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens
|
|
CN105085620B
(zh)
|
2015-06-25 |
2018-05-08 |
中山大学附属第一医院 |
一种靶向泛素化降解Smad3的化合物
|
|
US11179348B2
(en)
|
2015-07-21 |
2021-11-23 |
Fundación Universidad Católica De Valencia San Vicente Mártir |
Combination comprising pterostilbene for the treatment of cancer
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
US11111259B2
(en)
*
|
2015-12-18 |
2021-09-07 |
Unity Biotechnology, Inc. |
Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
|
|
CN109152933B
(zh)
|
2016-04-21 |
2022-12-02 |
生物风险投资有限责任公司 |
诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途
|
|
US20190054097A1
(en)
|
2016-04-21 |
2019-02-21 |
Bioventures, Llc |
Compositions targeting senescent cells and the uses thereof
|
|
US10296352B2
(en)
|
2016-06-15 |
2019-05-21 |
University Of Southern California |
Nested quantum annealing correction
|
|
ES3041854T3
(en)
|
2018-01-22 |
2025-11-17 |
Bioventures Llc |
Bcl-2 proteins degraders for cancer treatment
|